![Vinzenz Ploerer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vinzenz Ploerer
Directeur Général chez
Brace Pharmaceuticals, Inc.
Profil
Vinzenz Ploerer is currently the President & Chief Executive Officer at Brace Pharmaceuticals, Inc., Director at Antiva Biosciences, Inc., and Director at Navitor Pharmaceuticals, Inc. He was previously the Chairman & Chief Executive Officer at Therabron Therapeutics, Inc., and a Director at Vero Biotech LLC and Tyrogenex, Inc. Ploerer holds an MBA degree from the University of Innsbruck.
Postes actifs de Vinzenz Ploerer
| Sociétés | Poste | Début |
|---|---|---|
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. BiotechnologyHealth Technology Provides antiviral therapeutics | Directeur/Membre du Conseil | - |
Brace Pharmaceuticals, Inc.
 Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals invests in companies located in the United States and Brazil. The firm targets companies operating in the fields of bio-pharmaceuticals and biotech. It provides financing for early and late stage capital requirements. | Directeur Général | - |
Anciens postes connus de Vinzenz Ploerer
| Sociétés | Poste | Fin |
|---|---|---|
Vero Biotech, Inc.
 Vero Biotech, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that focused on the design, development and commercialization of inhaled nitric oxide delivery systems | Directeur/Membre du Conseil | - |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted therapeutics | Directeur/Membre du Conseil | - |
Therabron Therapeutics, Inc.
 Therabron Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Directeur Général | - |
Tyrogenex, Inc.
 Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Offers drug discovery and development focused on small molecule kinase inhibitors | Directeur/Membre du Conseil | - |
Formation de Vinzenz Ploerer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Vero Biotech, Inc.
Vero Biotech, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that focused on the design, development and commercialization of inhaled nitric oxide delivery systems | Health Technology |
Therabron Therapeutics, Inc.
Therabron Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. BiotechnologyHealth Technology Provides antiviral therapeutics | Health Technology |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted therapeutics | Health Technology |
University of Innsbruck
 University of Innsbruck Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tyrogenex, Inc.
Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Offers drug discovery and development focused on small molecule kinase inhibitors | Health Technology |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals invests in companies located in the United States and Brazil. The firm targets companies operating in the fields of bio-pharmaceuticals and biotech. It provides financing for early and late stage capital requirements. | Finance |
